\-\ Texto\\:\\ \ \(0\)\
\-\ initial\\ vital\\ signs\\ demonstrated\\ significant\\ hypertension\\ \\(150\\/90\\)\ \(0\)\
\-\ lowering\\ the\\ blood\\ pressure\\ is\\ usually\\ sufficient\\ to\\ reverse\\ the\\ symptoms\\ and\\ findings\\.\\ \\ however\\,\\ diuretics\\ and\\ ace\\ inhibitors\\ are\\ contraindicated\\ in\\ pregnancy\\.\\ ht\\ is\\ treated\\ with\\ beta\\-blockers\\,\\ methyldopa\\,\\ and\\ hydralazine\\.\\ magnesium\\ sulfate\\ is\\ used\\ to\\ control\\ seizures\\.\ \(0\)\
\-\ bilateral\\ occipital\\ lesions\\ of\\ abnormal\\ decreased\\ attenuation\\ \\-\\ mostly\\ in\\ the\\ posterior\\ white\\ matter\\,\\ with\\ some\\ areas\\ also\\ involving\\ into\\ the\\ cortical\\ gray\\ matter\\.\ \(0\)\
\-\ reversible\\ posterior\\ leukoencephalopathy\\ from\\ eclampsia\\ \\(toxemia\\ of\\ pregnancy\\)\ \(0\)\
\-\ \\<li\\>top\\ of\\ the\\ basilar\\ syndrome\ \(0\)\
\-\ \\<li\\>superior\\ sagittal\\ sinus\\ thrombosis\ \(0\)\
\-\ \\<li\\>eclampsia\ \(0\)\
\-\ \\<li\\>cyclosporin\\ toxicity\ \(0\)\
\-\ \\<li\\>pres\\ \\(posterior\\ reversible\\ encephalopathy\\ syndrome\\)\ \(0\)\
\-\ this\\ 20\\ year\\ old\\ pregnant\\ woman\\ presented\\ to\\ the\\ emergency\\ room\\ with\\ decreased\\ vision\\ following\\ a\\ seizure\\.\ \(0\)\
\-\ companion\\ cases\\:\ \(4\)\
\-\ http\\:\\/\\/rad\\.usuhs\\.edu\\/medpix\\/parent\\.php3\\?mode\\=tfcase\\_thumbnails\\&case\\_prog\\=\\/medpix\\/cow\\_image\\.php\\&pt\\_id\\=12932\ \(0\)\
\-\ http\\:\\/\\/www\\.vh\\.org\\/providers\\/clinref\\/fphandbook\\/chapter14\\/12\\-14\\.html\ \(0\)\
\-\ http\\:\\/\\/www\\.acponline\\.org\\/journals\\/ebm\\/janfeb96\\/magsul1\\.htm\ \(1\)\
\-\ http\\:\\/\\/bmj\\.com\\/cgi\\/content\\/full\\/318\\/7186\\/751\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ li\\:\\ 0\\.3457399848695693\ \(0\)\
\-\ http\\:\\ 0\\.21565306821020294\ \(0\)\
\-\ eclampsia\\:\\ 0\\.18965761360213448\ \(0\)\
\-\ reversible\\:\\ 0\\.16866677946486022\ \(0\)\
\-\ pregnancy\\:\\ 0\\.11935584982715927\ \(0\)\
\-\ hydralazine\\:\\ 0\\.11662230992351867\ \(0\)\
\-\ toxemia\\:\\ 0\\.11662230992351867\ \(0\)\
\-\ posterior\\:\\ 0\\.11312981779339698\ \(0\)\
\-\ methyldopa\\:\\ 0\\.11143884314632604\ \(0\)\
\-\ matter\\:\\ 0\\.11105197068800811\ \(0\)\
\-\ cyclosporin\\:\\ 0\\.10776111493956274\ \(0\)\
\-\ magnesium\\:\\ 0\\.10257764816237011\ \(0\)\
\-\ lowering\\:\\ 0\\.10060698555395377\ \(0\)\
\-\ sulfate\\:\\ 0\\.09889991995560682\ \(0\)\
\-\ diuretics\\:\\ 0\\.09739418138517748\ \(0\)\
\-\ inhibitors\\:\\ 0\\.09269318703865145\ \(0\)\
\-\ reverse\\:\\ 0\\.0908637855588038\ \(0\)\
\-\ decreased\\:\\ 0\\.09034198775109999\ \(0\)\
\-\ pres\\:\\ 0\\.09003872497165087\ \(0\)\
\-\ contraindicated\\:\\ 0\\.08926369968148083\ \(0\)\
\-\ toxicity\\:\\ 0\\.08853298640122155\ \(0\)\
\-\ syndrome\\:\\ 0\\.08792682894274499\ \(0\)\
\-\ ace\\:\\ 0\\.0878417909331399\ \(0\)\
\-\ leukoencephalopathy\\:\\ 0\\.0878417909331399\ \(0\)\
\-\ the\\:\\ 0\\.08730659968815169\ \(0\)\
\-\ ht\\:\\ 0\\.08539934039284833\ \(0\)\
\-\ sufficient\\:\\ 0\\.0804025046975249\ \(0\)\
\-\ companion\\:\\ 0\\.07864852527750289\ \(0\)\
\-\ encephalopathy\\:\\ 0\\.07681912379765522\ \(0\)\
\-\ pregnant\\:\\ 0\\.07653814540889238\ \(0\)\
\-\ mostly\\:\\ 0\\.07626321003705118\ \(0\)\
\-\ top\\:\\ 0\\.07117073298247559\ \(0\)\
\-\ basilar\\:\\ 0\\.06899303747590195\ \(0\)\
\-\ vital\\:\\ 0\\.06493593418803541\ \(0\)\
\-\ vision\\:\\ 0\\.06315897228621066\ \(0\)\
\-\ occipital\\:\\ 0\\.062401179982779185\ \(0\)\
\-\ gray\\:\\ 0\\.062401179982779185\ \(0\)\
\-\ control\\:\\ 0\\.06230953799851965\ \(0\)\
\-\ seizure\\:\\ 0\\.06068262314585203\ \(0\)\
\-\ is\\:\\ 0\\.05991269086009004\ \(0\)\
\-\ room\\:\\ 0\\.059677924913579636\ \(0\)\
\-\ seizures\\:\\ 0\\.05953013133619241\ \(0\)\
\-\ thrombosis\\:\\ 0\\.05945687037890926\ \(0\)\
\-\ sagittal\\:\\ 0\\.05607473920407948\ \(0\)\
\-\ hypertension\\:\\ 0\\.05579741808956835\ \(0\)\
\-\ attenuation\\:\\ 0\\.05579741808956835\ \(0\)\
\-\ pressure\\:\\ 0\\.055525985344004054\ \(0\)\
\-\ to\\:\\ 0\\.05469301969590225\ \(0\)\
\-\ used\\:\\ 0\\.054593945035827145\ \(0\)\
\-\ emergency\\:\\ 0\\.054104076595663124\ \(0\)\
\-\ sinus\\:\\ 0\\.05269482151762154\ \(0\)\
\-\ cortical\\:\\ 0\\.052355027373179944\ \(0\)\
\-\ involving\\:\\ 0\\.05107955273820552\ \(0\)\
\-\ signs\\:\\ 0\\.05096625212604671\ \(0\)\
\-\ areas\\:\\ 0\\.04951074545545089\ \(0\)\
\-\ cases\\:\\ 0\\.04904941697424743\ \(0\)\
\-\ initial\\:\\ 0\\.048920609818470503\ \(0\)\
\-\ white\\:\\ 0\\.048113584506436324\ \(0\)\
\-\ superior\\:\\ 0\\.04741131173192193\ \(0\)\
\-\ 20\\:\\ 0\\.047046430702441897\ \(0\)\
\-\ usually\\:\\ 0\\.04590873712687435\ \(0\)\
\-\ some\\:\\ 0\\.04588344730248501\ \(0\)\
\-\ treated\\:\\ 0\\.0454122086177607\ \(0\)\
\-\ and\\:\\ 0\\.04520692686387455\ \(0\)\
\-\ demonstrated\\:\\ 0\\.044817496642066794\ \(0\)\
\-\ abnormal\\:\\ 0\\.043812122740437734\ \(0\)\
\-\ following\\:\\ 0\\.04374782754006923\ \(0\)\
\-\ however\\:\\ 0\\.04316283650017921\ \(0\)\
\-\ with\\:\\ 0\\.042838644673027504\ \(0\)\
\-\ of\\:\\ 0\\.04281306387756245\ \(0\)\
\-\ presented\\:\\ 0\\.04252549569957441\ \(0\)\
\-\ blood\\:\\ 0\\.04235182356667062\ \(0\)\
\-\ significant\\:\\ 0\\.04210505714209078\ \(0\)\
\-\ lesions\\:\\ 0\\.041881424581251\ \(0\)\
\-\ symptoms\\:\\ 0\\.0399002097625288\ \(0\)\
\-\ bilateral\\:\\ 0\\.03919237062322541\ \(0\)\
\-\ into\\:\\ 0\\.03876546157131572\ \(0\)\
\-\ woman\\:\\ 0\\.03797936972298658\ \(0\)\
\-\ in\\:\\ 0\\.036282547177488106\ \(0\)\
\-\ findings\\:\\ 0\\.035991214748703496\ \(0\)\
\-\ also\\:\\ 0\\.034301641516223266\ \(0\)\
\-\ from\\:\\ 0\\.02896255913806322\ \(0\)\
\-\ are\\:\\ 0\\.027671568822253183\ \(0\)\
\-\ this\\:\\ 0\\.02505820556490882\ \(0\)\
\-\ year\\:\\ 0\\.022473925724492142\ \(0\)\
\-\ old\\:\\ 0\\.021582748237963592\ \(0\)\
